Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.

Tepper NK, Krashin JW, Curtis KM, Cox S, Whiteman MK

Open source

DOI
10.15585/mmwr.mm6637a6
Published
2017 Sep 22
Container
MMWR. Morbidity and mortality weekly report
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15585/mmwr.mm6637a6,
  title = {Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.},
  author = {Tepper NK and Krashin JW and Curtis KM and Cox S and Whiteman MK},
  year = {2017},
  journal = {MMWR. Morbidity and mortality weekly report},
  doi = {10.15585/mmwr.mm6637a6},
  url = {https://doi.org/10.15585/mmwr.mm6637a6}
}

RIS

TY  - JOUR
TI  - Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.
AU  - Tepper NK
AU  - Krashin JW
AU  - Curtis KM
AU  - Cox S
AU  - Whiteman MK
PY  - 2017
JO  - MMWR. Morbidity and mortality weekly report
DO  - 10.15585/mmwr.mm6637a6
UR  - https://doi.org/10.15585/mmwr.mm6637a6
ER  - 

APA

NK, T., JW, K., KM, C., S, C., & MK, W. (2017). Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.. MMWR. Morbidity and mortality weekly report. https://doi.org/10.15585/mmwr.mm6637a6

Source records